1. Home
  2. PRZO vs SLXN Comparison

PRZO vs SLXN Comparison

Compare PRZO & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRZO
  • SLXN
  • Stock Information
  • Founded
  • PRZO 2014
  • SLXN 2008
  • Country
  • PRZO Israel
  • SLXN Israel
  • Employees
  • PRZO N/A
  • SLXN N/A
  • Industry
  • PRZO
  • SLXN
  • Sector
  • PRZO
  • SLXN
  • Exchange
  • PRZO Nasdaq
  • SLXN NYSE
  • Market Cap
  • PRZO 20.1M
  • SLXN 7.3M
  • IPO Year
  • PRZO 2023
  • SLXN N/A
  • Fundamental
  • Price
  • PRZO $1.61
  • SLXN $0.80
  • Analyst Decision
  • PRZO
  • SLXN Strong Buy
  • Analyst Count
  • PRZO 0
  • SLXN 1
  • Target Price
  • PRZO N/A
  • SLXN $5.00
  • AVG Volume (30 Days)
  • PRZO 2.1M
  • SLXN 707.7K
  • Earning Date
  • PRZO 09-02-2025
  • SLXN 08-21-2025
  • Dividend Yield
  • PRZO N/A
  • SLXN N/A
  • EPS Growth
  • PRZO N/A
  • SLXN N/A
  • EPS
  • PRZO N/A
  • SLXN N/A
  • Revenue
  • PRZO $932,154.00
  • SLXN N/A
  • Revenue This Year
  • PRZO N/A
  • SLXN N/A
  • Revenue Next Year
  • PRZO N/A
  • SLXN N/A
  • P/E Ratio
  • PRZO N/A
  • SLXN N/A
  • Revenue Growth
  • PRZO 50.22
  • SLXN N/A
  • 52 Week Low
  • PRZO $0.49
  • SLXN $0.58
  • 52 Week High
  • PRZO $3.16
  • SLXN $41.85
  • Technical
  • Relative Strength Index (RSI)
  • PRZO 67.69
  • SLXN N/A
  • Support Level
  • PRZO $1.37
  • SLXN N/A
  • Resistance Level
  • PRZO $1.52
  • SLXN N/A
  • Average True Range (ATR)
  • PRZO 0.10
  • SLXN 0.00
  • MACD
  • PRZO 0.03
  • SLXN 0.00
  • Stochastic Oscillator
  • PRZO 74.06
  • SLXN 0.00

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.

Share on Social Networks: